Oxford Nanopore Technologies plc (LON:ONT)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 1.11B +11.8% |
| Revenue (ttm) | 223.90M +22.2% |
| Net Income | -145.20M |
| EPS | -0.15 |
| Shares Out | 967.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,057,159 |
| Average Volume | 1,529,456 |
| Open | 115.00 |
| Previous Close | 115.20 |
| Day's Range | 114.47 - 122.80 |
| 52-Week Range | 96.35 - 224.80 |
| Beta | 0.88 |
| RSI | 43.89 |
| Earnings Date | Aug 19, 2026 |
About LON:ONT
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its cu... [Read more]
Financial Performance
In 2025, LON:ONT's revenue was 223.90 million, an increase of 22.22% compared to the previous year's 183.19 million. Losses were -145.20 million, -0.68% less than in 2024.
Financial StatementsNews
Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan
OXFORD, England & TOKYO--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations...
ViruSure Launches First GMP-Validated Viral Safety Test Based on Oxford Nanopore Sequencing
OXFORD, England & VIENNA--(BUSINESS WIRE)-- #Nanopore--ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's f...
Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company's first IVD device registered in t...
Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in...
ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
OXFORD, England & VIENNA, Austria--(BUSINESS WIRE)-- #Lifesciences--ViruSure, a global leader in pathogen safety testing for biopharmaceuticals, and Oxford Nanopore Technologies (“Oxford Nanopore”) (L...
Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore Simplex reads
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--A new paper, released this week on bioRxiv, introduces hifiasm-ONT, a breakthrough genome assembly algorithm that enables partially phased, near telomere-...
Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose pr...
Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK Biob...
Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a landmark strategic partnership with the UK ...
Oxford Nanopore Technologies and Plasmidsaurus Announce Strategic Collaboration to Advance Plasmid Sequencing
OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, th...
Oxford Nanopore Technologies (ONT) - Product Pipeline Analysis 2024
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Oxford Nanopore Technologies Plc (ONT) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. Oxf...
Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI...
Oxford Nanopore launches PromethION 2 Integrated into open early access
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its P...
Britain's Oxford Nanopore's shares sink after revenue warning
Shares in Britain's Oxford Nanopore dropped nearly 12% on Tuesday, after the sensing technology company issued a revenue warning, citing a slowdown in China and the Middle East, along with staggered p...
Oxford Nanopore and WeNou Announce a Partnership to Develop and Commercialise the First Rapid and Portable Food Authenticity Sequencing Test to Detect Food Fraud
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) and WeNou, a company providing innovative services based on DNA analysis for the food and feed sectors, today announce ...
Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the nanopore-sequencing company delivering unparalleled rich genomic data insights, and Fabric Genomics, the leadi...
Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing
OXFORD, United Kingdom--(BUSINESS WIRE)-- #genomics--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Sap...
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
ROCHESTER, Minn. & OXFORD, England--(BUSINESS WIRE)--Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today unveile...
The University of Queensland and Oxford Nanopore Technologies Team up to Accelerate Research Into Quality Control Testing for mRNA Vaccines
OXFORD, England & BRISBANE, Australia--(BUSINESS WIRE)--Researchers at The University of Queensland are harnessing the latest sequencing technology developed by UK-based biotech Oxford Nanopore Techno...
NIH Center for Alzheimer's and Related Dementias publication shows comprehensive, high accuracy sequencing approach, using new Oxford Nanopore sequencing chemistry
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore sequencing technology has been used by a team led by researchers at the National Institutes of Health Center for Alzheimer's and Related Dementias (CA...
Oxford Nanopore announces education collaboration with Cold Spring Harbor DNA Learning Center and launches pilot accessible sequencing education programme
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of “Education beta”, its pilot education programme and the first of its kind in the world de...
Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Geneyx, an AI platform...
Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
OXFORD, England & MARCY-L'ETOILE, France--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing ...
Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational Integr...
Oxford Nanopore and 4bases Announce Collaboration to Combine Nanopore Sequencing Devices and 4bases Kits to Support Rapid, High-accuracy Analyses in Human and Cancer Genetics, with a First Target of Same-day BRCA1 and BRCA2 Analysis
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore) and 4bases, a Switzerland-based company, specialising in kits for sequencing and bioinformatic tools, today announc...